SCHEMBL16683424

SCHEMBL16683424

COC(=O)c1cc(Br)ccc1-c1cc2sc(-c3ccc(Br)cc3C(=O)OC)cc2s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A3 Q01959 1/20 0.47
▸ NR4A2 P43354 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ GAA P10253 2/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ MAPT P10636 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CHEK1 O14757 1/20 0.40
▸ PRKCZ Q05513 1/20 0.40
▸ RAB9A P51151 1/20 0.39
▸ HPGD P15428 3/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30580716 0.88 NR4A2 (0.47) SLC6A3NR4A2ALDH1A1GAASMN1; SMN2
SCHEMBL20043732 0.88 NR4A2 (0.47) SLC6A3NR4A2ALDH1A1GAASMN1; SMN2
SCHEMBL16683423 0.84 MAPT (0.49) ALDH1A1GAASMN1; SMN2L3MBTL1MAPT
SCHEMBL2482051 0.84 NR4A2 (0.54) SLC6A3NR4A2ALDH1A1GAASMN1; SMN2
SCHEMBL18195802 0.81 ALDH1A1 (0.48) SLC6A3NR4A2ALDH1A1GAASMN1; SMN2
SCHEMBL1577095 0.81 SLC6A3 (0.69) SLC6A3NR4A2ALDH1A1GAASMN1; SMN2
SCHEMBL19603559 0.79 MAPT (0.55) SLC6A3NR4A2ALDH1A1GAASMN1; SMN2
SCHEMBL12737920 0.79 SLC6A3 (0.66) SLC6A3NR4A2ALDH1A1GAASMN1; SMN2
SCHEMBL3168568 0.75 SLC6A3 (0.65) SLC6A3NR4A2ALDH1A1GAAL3MBTL1
SCHEMBL4577829 0.75 NR4A2 (0.56) SLC6A3NR4A2ALDH1A1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11839155-B2 Organic semiconducting compounds RAYNERGY TEK INC. (TW) 2023-12-05 — — US disclosed
EP-3523308-B1 ORGANIC SEMICONDUCTING COMPOUNDS RAYNERGY TEK INC (TW) 2023-09-06 — — EP disclosed
EP-3060622-B1 CONJUGATED POLYMERS MERCK PATENT GMBH (DE) 2019-06-19 — — EP disclosed
WO-2018065350-A1 ORGANIC SEMICONDUCTING COMPOUNDS MERCK PATENT GMBH (DE) 2018-04-12 — — WO disclosed
WO-2018065352-A1 ORGANIC PHOTODETECTOR MERCK PATENT GMBH (DE) 2018-04-12 — — WO disclosed
WO-2018065356-A1 ORGANIC SEMICONDUCTING COMPOUNDS MERCK PATENT GMBH (DE) 2018-04-12 — — WO disclosed
US-9806263-B2 Conjugated polymers MERCK PATENT GMBH (DE) 2017-10-31 — — US disclosed
US-9806263-B2 Conjugated polymers MERCK PATENT GMBH (DE) 2017-10-31 — — US disclosed
US-20160276591-A1 CONJUGATED POLYMERS MERCK PATENT GMBH (DE) 2016-09-22 — — US disclosed
US-20160276591-A1 CONJUGATED POLYMERS MERCK PATENT GMBH (DE) 2016-09-22 — — US disclosed
WO-2015058827-A1 CONJUGATED POLYMERS MERCK PATENT GMBH (DE) 2015-04-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11839155-B2 Organic semiconducting compounds OCIAD2, OCIAD1, OSTC SLC6A3 1311/4885NR4A2 2059/4885ALDH1A1 2672/4885
US-20160276591-A1 CONJUGATED POLYMERS OCIAD2, OCIAD1, DDT SLC6A3 1172/4885NR4A2 1593/4885ALDH1A1 2865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback